A pathogenic role for Gal-3 was proposed in systemic sclerosis (SSc) due to its known association with different hallmarks of this disease9,10, namely pulmonary, cardiac, renal, and cutaneous fibrosis, inflammation, and pulmonary arterial hypertension5,7,11. This evidence concerns the gene LGALS3 and systemic sclerosis.